ICH has produced a comprehensive set of guidelines to uncover potential risks like carcinogenicity, genotoxicity and reprotoxicity. A recent breakthrough has been a non-clinical testing strategy for assessing the QT Interval prolongation liability: the single most important cause of drug withdrawals in recent years